Provided by Tiger Trade Technology Pte. Ltd.

Sunshine Biopharma Equity Warrant Warrant

0.1650
0.0000
Volume:- -
Turnover:- -
Market Cap:3.73M
PE:-0.08
High:0.1650
Open:0.1650
Low:0.1650
Close:0.1650
52wk High:0.9802
52wk Low:0.1100
Shares:22.59M
Float Shares:18.30M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.0276
EPS(LYR):-4.7612
ROE:-13.08%
ROA:-11.29%
PB:0.09
PE(LYR):-0.03

Loading ...

Company Profile

Company Name:
Sunshine Biopharma Equity Warrant Warrant
Exchange:
NASDAQ
Establishment Date:
- -
Employees:
- -
Office Location:
- -
Zip Code:
- -
Phone:
- -
Fax:
- -
Introduction:
Sunshine Biopharma, Inc., a pharmaceutical company, focuses on the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals in the United States and Canada. It operates in two segments, Prescription Generic Pharmaceuticals and Nonprescription Over-The-Counter Products. The company is developing SBFM-PL4, a protease inhibitor for the treatment of SARS coronavirus infections; Adva-27a, a small chemotherapy molecule to treat pancreatic cancer; and K1.1 mRNA, a lipid nano-particle for liver cancer. It also offers Essential 9, an amino acids capsules; Calcium-Vitamin D supplement under the Essential Calcium-Vitamin D brand name; and L-Citrulline and Taurine products. In addition, the company provides various generic prescription drugs for osteoporosis, cardiovascular, antipsychotic, antibacterial, hypertension, anti-inflammatory, allergy, antibiotic, central nervous system, diabetes, urology, antifungal, antimalarial, oncology, gastroenterology, and anticonvulsant indications. Sunshine Biopharma, Inc. is based in Fort Lauderdale, Florida.